Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study

1. Orkin, C.
2. Bernal Morell, E.
3. Tan, D.H.S.
4. Katner, H.
5. Stellbrink, H.-J.
6. Belonosova, E.
7. DeMoor, R.
8. Griffith, S.
9. Thiagarajah, S.
10. Van Solingen-Ristea, R.
11. Ford, S.L.
12. Crauwels, H.
13. Patel, P.
14. Cutrell, A.
15. Smith, K.Y.
16. Vandermeulen, K.
17. Birmingham, E.
18. St Clair, M.
19. Spreen, W.R.
20. D'Amico, R.